CNR2 and breast carcinoma: In breast cancer cases, a correlation has been established between CB2 and tumour aggressiveness as compared to CB1, and due to the low affinity between CBD and the CB receptors, the involvement of TRPV1 receptors has been suggested to play a crucial role in CBD’s anti-cancer activity on breast cancer cells.